Loading page
Loading page
Loading substance route
Dosing information is tentative and limited. Further research is recommended. A notable gap exists between light and moderate dose ranges in available documentation.
Insufflation is reported to be not well-tolerated, suggesting potential for local irritation or discomfort via this route.
βk-2C-B was first described in the scientific literature by Richard Glennon and colleagues in 2004. Despite being the β-keto derivative of the well-known psychedelic 2C-B, the compound was not included or mentioned in Alexander Shulgin's seminal work PiHKAL (Phenethylamines I Have Known and Loved).…